Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Insulet has filed a registration statement relating to an underwritten public offering of 4.89 million shares of its common stock, all of which are being sold by selling stockholders.
Subscribe to our email newsletter
Medical device maker Insulet has granted the underwriters the right to purchase up to an additional 734,759 shares to cover over-allotments, if any. Insulet will not receive any proceeds from the sale of shares by the selling stockholders.
JP Morgan Securities and Merrill Lynch, Pierce, Fenner & Smith will serve as joint book-running managers, and Leerink Swann & Co, Thomas Weisel Partners and Canaccord Adams will serve as co-managers for the proposed offering.